Cargando…
Protein Levels of Anti-Apoptotic Mcl-1 and the Deubiquitinase USP9x Are Cooperatively Upregulated during Prostate Cancer Progression and Limit Response of Prostate Cancer Cells to Radiotherapy
SIMPLE SUMMARY: Radiotherapy constitutes an important therapeutic option for prostate cancer. However, prostate cancer cells often acquire resistance during cancer progression, limiting the cytotoxic effects of radiotherapy. Among factors regulating sensitivity to radiotherapy are members of the Bcl...
Autores principales: | Hogh-Binder, Sophia A., Klein, Diana, Wolfsperger, Frederik, Huber, Stephan M., Hennenlotter, Jörg, Stenzl, Arnulf, Rudner, Justine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177233/ https://www.ncbi.nlm.nih.gov/pubmed/37173959 http://dx.doi.org/10.3390/cancers15092496 |
Ejemplares similares
-
Deubiquitylating enzyme USP9x regulates radiosensitivity in glioblastoma cells by Mcl-1-dependent and -independent mechanisms
por: Wolfsperger, F, et al.
Publicado: (2016) -
The deubiquitinase (DUB) USP13 promotes Mcl-1 stabilisation in cervical cancer
por: Morgan, Ethan L., et al.
Publicado: (2021) -
Deubiquitinase USP13 dictates MCL1 stability and sensitivity to BH3 mimetic inhibitors
por: Zhang, Shengzhe, et al.
Publicado: (2018) -
Targeting deubiquitinase USP28 for cancer therapy
por: Wang, Xiaofang, et al.
Publicado: (2018) -
Deubiquitinase USP9X regulates the invasion of prostate cancer cells by regulating the ERK pathway and mitochondrial dynamics
por: Zhang, Jinsong, et al.
Publicado: (2019)